Right, which I believe is an issue for those who are not in the 20-30% that have excessive GM-CSF.
Ohm, do you think that Leronlimabs MOA targeting RANTES offers a "safer" down regulation of GM-CSF, in that it really cant force it to be TOO LOW?
(0)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-